Increase of RNA synthesis during mammary tumor regression.
D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology; D001551:Benz(a)Anthracenes; D002369:Castration; D002460:Cell Line; D002467:Cell Nucleus / Q000378:metabolism; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D004958:Estradiol / Q000494:pharmacology; D004967:Estrogens / Q000502:physiology; D005260:Female; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000378:metabolism*; D009363:Neoplasm Proteins / Q000096:biosynthesis; D011691:Puromycin / Q000494:pharmacology; D012334:RNA, Neoplasm / Q000096:biosynthesis*; D051381:Rats; D013997:Time Factors; D014316:Tritium; D014529:Uridine / Q000378:metabolism
D000963:Antimetabolites; D001551:Benz(a)Anthracenes; D004967:Estrogens; D009363:Neoplasm Proteins; D012334:RNA, Neoplasm; D014316:Tritium; D003609:Dactinomycin; D011691:Puromycin; D004958:Estradiol; D003513:Cycloheximide; D014529:Uridine